Market Place
Sourcing Support
Regor, Genentech to Acquire Regor`s Portfolio for CDK of Breast Cancer
30 Sep 2024 //
PR NEWSWIRE
Regor Initiates Phase 2 Study of Oral Once-daily GLP-1 Agonist RGT-075
08 Mar 2024 //
PR NEWSWIRE
Regor Announces Safety And Single Agent Efficacy Data Evaluating RGT-419B
07 Dec 2023 //
PR NEWSWIRE
Regor notches minor victory in trade secrets feud with Pfizer
08 Feb 2023 //
FIERCE BIOTECH
Ex-Pfizer staffers slap back at trade secret stealing accusations
24 Mar 2022 //
ENDPTS
Building a New Generation AI Engine and Jointly Accelerating World-Class Innovative Drug Discovery and Development
24 Mar 2022 //
PRESS RELEASE
Pfizer accuses former employees of stealing trade secrets
04 Feb 2022 //
STATNEWS
FDA Authorizes Regor`s First-in-Human Clinical Trial with RGT-419B for Oncology
28 Dec 2021 //
ASIAONE
Lilly and Regor sign deal to develop treatments for metabolic disorders
10 Dec 2021 //
PHARMACEUTICAL-TECHNOLOGY
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.